-
N3-kethoxal: Reading Nucleic Acid Exposure
2026-09-10
N3-kethoxal converts transient guanine exposure into a covalent, click-ready signal for RNA structure and DNA accessibility studies. This article explains how R-loop biology changes interpretation, controls, and assay design.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-10
Build reproducible DNA delivery workflows for reporter assays, transient gene expression, and recombinant protein production with a serum-compatible linear polymer. This guide connects PEI optimization to follow-up studies of arctigenin, KEAP1-NRF2 signaling, oxidative stress, and doxorubicin-induced cardiotoxicity.
-
25-Hydroxycholesterol Reprograms Immunosuppressive TAMs
2026-09-09
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that connects lysosomal lipid handling to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows that targeting CH25H can reduce ARG1-dependent immunosuppression, increase T-cell activity, and improve responses to anti-PD-1 therapy.
-
FBXO22 Ligands Expand Targeted Protein Degradation
2026-09-09
A 2025 bioRxiv preprint reports chemical probes that selectively degrade FBXO22 and use it as a recruitment ligase for targeted protein degradation. Its identification of 2-pyridinecarboxaldehyde as a reversible cysteine-reactive degron broadens the ligand chemistry available for degrading proteins such as BRD4 and CDK12.
-
740 Y-P for Reliable PI3K Assays
2026-09-08
Learn how 740 Y-P (SKU B5246) can be integrated into cell viability, apoptosis, neuronal survival, and vesicular trafficking workflows. This scenario-based guide covers pathway interpretation, stock preparation, controls, assay compatibility, and evidence-based product selection.
-
Protein A/G Magnetic Beads for TPM3 Co-IP
2026-09-07
A practical guide to using Protein A/G Magnetic Beads for antibody capture, TPM3–HDAC3 co-immunoprecipitation, and post-translational modification studies. The workflow emphasizes low-background controls, assay-specific optimization, and translation of vascular biology findings into reproducible protein-interaction experiments.
-
MEK1/2, c-Myc, and TERT in Human Stem Cells
2026-09-07
The reference study identifies a chromatin-based mechanism through which MEK1/2 and c-Myc:MAX cooperate to maintain TERT transcription in human embryonic stem cells. Its findings connect MAPK signaling with PRC2-dependent repression at the TERT promoter and provide a framework for testing how pathway inhibition affects telomere biology and stem-cell proliferation.
-
E-64 for Cathepsin S Assay Design in Lymphoma
2026-09-05
E-64 enables mechanistically rigorous cysteine protease inhibition studies, but its broad covalent activity requires careful interpretation in lymphoma models. This article connects E-64 assay design with cathepsin S biology, antigen processing, and practical cancer research decisions.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-04
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, IHC, flow cytometry, and compatible ELISA workflows. It should not be used as a general secondary for non-goat primaries or treated as validated for applications outside the product dossier and assay-specific optimization.
-
M344: An Assay-First Guide to Epigenetic Evidence
2026-09-04
M344 is a cell-permeable histone deacetylase inhibitor for connecting chromatin remodeling with proliferation, differentiation, and viral-latency assays. This assay-first guide explains how to interpret its evidence, choose endpoints, and avoid overextending findings across disease models.
-
TAK-715: Practical p38 MAPK Inhibition Workflows
2026-09-04
TAK-715 combines nanomolar p38α inhibition with a workflow-friendly profile for cytokine, stress-response, and rheumatoid arthritis research. This guide translates its mechanism into cell-based assays, phosphatase-aware experiments, comparator studies, and practical troubleshooting steps.
-
Mitomycin C Workflows for DNA Damage Studies
2026-09-03
Mitomycin C enables controlled DNA replication inhibition, apoptosis profiling, and therapy-sensitization experiments across PC3 and colon cancer models. This practical guide connects concentration, timing, solubility, and pathway readouts to reproducible cancer research workflows while clearly separating established evidence from hypothesis-generating extensions.
-
Crizotinib Hydrochloride in Gastric Assembloids
2026-09-02
Explore how Crizotinib hydrochloride, an ALK kinase inhibitor, can be used in patient-derived gastric assembloids to separate target engagement from microenvironment-dependent drug response. This assay-focused framework extends organoid research toward more rigorous cancer biology research.
-
Triazole ALDH2 Activators in Myocardial Ischemia
2026-09-02
The 2025 ACS Medicinal Chemistry Letters study developed triazole-based aldehyde dehydrogenase 2 activators through molecular simulation, seeking to improve both enzyme activation and aqueous solubility. Lead compound Z17 produced strong biochemical activation and improved cardiac function, infarct burden, and injury biomarkers in a mouse ischemia–reperfusion model, while pharmacokinetic and clinical questions remain open.
-
Protein A/G Magnetic Beads: Practical Protocol
2026-09-01
Protein A/G Magnetic Beads provide Fc-directed capture for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin workflows involving IgG antibodies. This guide explains how to set up and troubleshoot the beads while defining limits for antibody compatibility, non-IgG applications, and uses outside research workflows.